Gala GLP-1 Review: $179 Compounded Tirzepatide and HRT for Midlife

Is Gala GLP-1 legit?

Start with the basics, because that's what an ad promising $179 GLP-1 makes you want to check first. Gala GLP-1 is operated by AI Coaching, Inc., a company registered in Wilmington, Delaware that does business as Gala GLP-1. It isn't a shell dropshipping supplements — prescriptions are written by clinicians at OpenLoop-affiliated medical groups, the same physician-staffing network that backs several established telehealth GLP-1 platforms, and Gala carries a LegitScript seal, a third-party verification that checks a pharmacy or telehealth operator's compliance with prescribing law rather than just its marketing claims.

Prescribing is available in all 50 states, though the exact consultation format and requirements shift a little by state. That combination — a registered company, real licensed prescribers, an independent compliance seal, and nationwide coverage — is what separates a legitimate telehealth operation from the GLP-1 grey market. What it doesn't tell you is whether the company is well run day to day, and that's a separate question worth its own section below.

The honest caveat: Gala is young. AI Coaching, Inc. was founded in 2024, its BBB file only opened in October 2025, and the site doesn't publish a named medical director or lab panel the way some longer-running competitors do. Legitimate and long-established aren't the same thing, and Gala is currently the first without yet being the second.

How much does Gala GLP-1 actually cost?

The headline product is compounded GLP-1/GIP — tirzepatide, the same dual-receptor molecule as Zepbound and Mounjaro, prepared by a compounding pharmacy rather than sold as Lilly's finished product. Gala prices it two ways: $179 a month if you commit to the yearly plan, or $199 a month on a 3-month plan. Every dose level is included in that number, so titrating up from a starter dose to a maintenance dose doesn't raise your bill, and the price bundles the intake assessment, the provider visit, ongoing dose adjustments, in-app messaging and shipping.

That's genuinely one of the lowest ongoing tirzepatide rates we track anywhere in this category. Against a year of treatment, the two plans work out to roughly $2,150 to $2,400 — cheaper than most compounded competitors and a fraction of paying cash for the branded drug.

Gala also sells brand-name Ozempic for patients who want the FDA-approved product specifically, at $1,299 a month — a price that isn't competitive once you know NovoCare's own self-pay program prices the same drug lower directly from the manufacturer. Treat the Ozempic line as a convenience option for people already committed to the brand, not a place to shop for value. A Wegovy pill is listed as coming soon, with pricing to be announced at launch.

The third piece of the platform is hormone therapy, starting at $69 a month, all included, covering estradiol pill or patch, progesterone, vaginal estradiol and non-hormonal options for hot flashes. Add that to the GLP-1 plan and a full year running both runs roughly $830 more than the GLP-1 alone — call it somewhere in the $2,900s to $3,200s a year combined, still well under what most women pay for either treatment separately through a specialist.

The catch before you commit: the plan term and the no-refund policy

The $179 rate isn't a month-to-month price — it's what you get by prepaying a full year. The 3-month plan at $199 is the shorter commitment, and there's no month-to-month option below that at all. Before you pick a term, read what happens if you change your mind, because Gala's refund policy is unambiguous on this point: cancellation does not get you money back. The policy states plainly that no refund is issued on cancellation of the subscription, with exactly one exception — a clinician disqualifying you on medical grounds, in which case the unused portion is refunded.

Cancelling itself is straightforward as long as you're early enough: Gala asks for at least 72 hours' notice before your next billing date. Miss that window and you're charged for another cycle before the cancellation takes effect. Damaged or incorrect shipments get replaced, not refunded, which is a normal policy elsewhere but worth knowing going in.

One more detail that catches people off guard: submitting the intake form starts your subscription and your first charge, before a clinician has actually reviewed whether you're a good candidate. If you're disqualified afterward, the medical-disqualification refund exception is what gets your money back — but you're paying before, not after, approval. Given all of that, the 3-month plan is the more forgiving way to try Gala than committing a full year upfront.

Reputation check: BBB C-, billing complaints, and the pharmacy Gala won't name

Gala's BBB profile currently shows a C- letter rating, no accreditation, and 26 customer complaints filed since the file opened in October 2025 — a high complaint count for a file that's less than a year old. Reading through the complaint pattern, the through-line is billing, not the medication itself: charges continuing after a cancellation request went in, a shipment arriving with only the cooler and supplies but no actual medication inside, and customers stuck messaging an AI chat system for weeks trying to reach an actual person.

The other piece worth flagging plainly: Gala never names the pharmacy that fills your prescription. The site refers only to 'licensed compounding pharmacies,' which means you can't independently check that pharmacy's accreditation, inspection history, or state licensure before you enroll — something a more established compounded-GLP-1 provider will usually tell you without hesitation. That opacity doesn't mean anything is wrong with the pharmacy Gala uses; it just means you're taking that part on faith rather than verifying it yourself.

How Gala GLP-1 works, from intake to your first shipment

The process is built to move fast, which is both the appeal and part of the billing catch described above.

• Complete an online intake covering health history, current medications and goals for weight or menopause symptoms.
• Submitting the form starts your subscription and the first charge — before a clinician has reviewed your case.
• An OpenLoop-affiliated clinician reviews your intake and either approves treatment or, occasionally, disqualifies you on medical grounds.
• If disqualified, the unused portion of your subscription is refunded — the one exception to the no-refund policy.
• If approved, your compounded tirzepatide, brand Ozempic or hormone prescription ships from an unnamed licensed compounding pharmacy, with free shipping bundled into the price.
• Ongoing dose adjustments and messaging with your care team happen through the free Gala GLP-1 Tracker app, which also logs weight and side effects.

What you're actually getting: compounded tirzepatide, brand Ozempic, and the HRT menu

It's worth being precise here, because Gala's own marketing language — 'compounded GLP-1/GIP' — can read as if multiple molecules are on offer. They aren't. GLP-1/GIP is simply the technical name for a dual-receptor agonist, and tirzepatide is the only molecule that fits that description; it's the same active ingredient as Zepbound and Mounjaro, just pharmacy-compounded rather than manufactured by Lilly. Gala does not compound semaglutide (the molecule in Ozempic and Wegovy) at all — its own product pages and pricing describe tirzepatide specifically, with no compounded-semaglutide line anywhere on the public site. If semaglutide is the molecule you want, Gala isn't the provider for it; you'd be looking at a platform like Mochi Health or Curex instead, both of which compound semaglutide alongside tirzepatide.

Compounded tirzepatide is the plan most people come to Gala for: it's for someone who wants the dual-agonist molecule's typically stronger weight-loss response, is comfortable with a compounded (not FDA-approved) product, and wants a price that stays flat regardless of dose.

Brand Ozempic is for a narrower group — patients who specifically want the FDA-approved, manufactured product and are willing to pay a real premium for it, since $1,299 a month is far above what the manufacturer itself charges self-pay patients directly. The Wegovy pill, still listed as coming soon, isn't a live option yet.

The hormone-health line is the piece that makes Gala distinct from most GLP-1-only telehealth brands. Estradiol pill or patch is the foundation for anyone managing hot flashes, sleep disruption or mood symptoms; progesterone is added for anyone with a uterus, both to protect the uterine lining and for its own sleep and anxiety benefits; vaginal estradiol targets local dryness and recurrent UTIs specifically, at a lower systemic dose; and the non-hormonal option exists for women who can't or don't want to use hormones at all. All of it starts at $69 a month, all included, on the same account as the GLP-1 plan.

Does Gala make sense in perimenopause or menopause?

The pitch that separates Gala from a generic weight-loss telehealth brand is having both prescriptions live in one place. Weight gain in the forties and fifties is frequently driven by the same hormonal shift that's causing hot flashes and sleep trouble, and having a clinician who can look at the GLP-1 and the hormone therapy together — rather than two separate providers who never see each other's notes — is a real advantage if that's your situation. Gala's own materials frame it explicitly: for a woman whose main concern is weight, the clinician can discuss whether a GLP-1 makes sense alongside hormone therapy, or instead of it, rather than assuming you want both.

That framing matters because GLP-1s and HRT solve different problems. A GLP-1 targets appetite and weight directly; HRT addresses the hormonal symptoms — hot flashes, sleep, mood, vaginal changes — that a GLP-1 doesn't touch at all. For a broader look at how the two compare and where they overlap, see our guide to GLP-1 medications and menopause weight gain.

Who Gala GLP-1 is for — and who should look elsewhere

• Good fit — cost-driven women 40+ who specifically want tirzepatide (not semaglutide), are comfortable with a compounded product, and can commit to a 3- or 12-month term.
• Good fit — anyone who wants one account handling both weight and perimenopause symptoms, rather than juggling two separate telehealth providers.
• Good fit — someone who wants a flat price that won't climb as they titrate, and values a tracking app over a coaching-heavy program.
• Look elsewhere — anyone who wants compounded semaglutide specifically; Gala doesn't offer it.
• Look elsewhere — anyone unwilling to prepay a multi-month term with no refund on cancellation.
• Look elsewhere — anyone who wants to verify the compounding pharmacy's accreditation before enrolling; Gala won't name it.

What real members say: Trustpilot vs. the complaint pattern

Gala's Trustpilot page tells a different story than its BBB file, and both can be true at once. Across roughly 4,100 reviews, Gala sits at 4.6 out of 5, with about 84% five-star — reviewers consistently praise fast shipping, responsive chat support for routine questions, and the free tracking app. That's a large, mostly satisfied customer base by volume.

The BBB complaints aren't really contradicting that picture; they're describing a different slice of it — the edge cases where something goes wrong with billing or a shipment, and where getting a human being to fix it takes real effort. A platform can have thousands of smooth, uneventful months and still leave two dozen customers stuck arguing with a chatbot about a charge that shouldn't have gone through. Read it as: the core service works for most people most of the time, and the failure mode when it doesn't is billing and support, not the medication itself.

Gala vs. Mochi Health and Curex: how the flat rate compares

On tirzepatide specifically, Gala's $179 to $199 a month is the lowest flat rate among the major compounded-GLP-1 platforms we track. Mochi Health charges a flat $199 medication fee for tirzepatide plus a separate $79 monthly membership, landing its real all-in cost near $278 a month — about $80 to $100 more than Gala, in exchange for an ABOM-certified physician network and, notably, four formats of compounded semaglutide if that's the molecule you actually want. Curex prices tirzepatide from around $199 a month with no separate membership fee at all, a simpler structure than Gala's prepaid terms, though its published rate is a starting figure rather than a guaranteed maintenance-dose price.

The trade-off is fairly clean. Gala wins on raw price and on pairing the GLP-1 with hormone therapy on one account. Mochi wins if you want semaglutide as an option or prefer obesity-medicine-credentialed physicians and don't mind the membership fee. Curex wins if a no-membership, no-prepay structure matters more to you than shaving another $20 a month off the rate. For the full field of compounded options side by side, see cheapest tirzepatide providers and best compounded GLP-1 pharmacy.